All Comments by

  1. David Holtzman on Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
  2. Richard Mayeux on Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.
  3. Benjamin Wolozin on Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.
  4. Benjamin Wolozin on Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
  5. Paul Coleman on In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.
  6. Paul Coleman on Neuronal cytoskeletal changes are an early consequence of repetitive head injury.
  7. Hiroshi Mori on The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.
  8. Paul Coleman on Does insulin dysfunction play a role in Alzheimer's disease?
  9. Paul Coleman on Tau neurotoxicity without the lesions: a fly challenges a tangled web.
  10. Paul Coleman on Parkinson's disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases.
  11. Bart De Strooper on Presenilin—Guilty of Proteolysis by Association?
  12. Benjamin Wolozin on Another Not-Quite-Parkinson's Model
  13. Todd E. Golde on Presenilin—Guilty of Proteolysis by Association?
  14. Elena Cattaneo on Mutant Huntingtin Linked to Mitochondrial Dysfunction
  15. Fred Van Leuven on Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease.